Menninger is involved in a number of research projects designed to advance the field of mental health as well as improve the treatment offered at The Clinic. These projects include:
McNair Initiative for Neuroscience Discovery-Menninger & Baylor College of Medicine (MIND-MB)
Principal investigator: Ramiro Salas, PhD
Co-investigators: Chris Fowler, PhD, Carla Sharp, PhD, David Nielsen, PhD, Philip Baldwin, PhD
MIND-MB is a comprehensive, five-year neuroscience research study designed to improve the identification of anatomical, physiological and genetic abnormalities and risk factors of mental illnesses. The research aims to increase understanding of mental disease progression and factors that impact treatment outcomes
. It will create a databank of adult and adolescent brain scans, genetic samples and assessments from approximately 2,500 adult and adolescent psychiatric patients suffering from multiple mental illnesses.
Participating patients undergo magnetic resonance imaging (MRI) as well as functional MRI (fMRI), which allows researchers to analyze the brain’s regions and neuronal connectivity during brain activity. Diffusion tensor imaging (DTI) is also conducted to analyze the nerve pathways in the brain.
A subset of Menninger patients are rescanned approximately 21 days after the initial brain scans are taken, once comprehensive treatment is well underway. This comparison, using the fMRI, allows researchers to see the difference in brain activity after a standard length of treatment has been completed.
Hospital-wide Outcomes Project
Principal investigator: Michelle Patriquin, PhD
Co-investigators: Chris Fowler, PhD, Thomas E. Ellis, PsyD, ABPP, B. Christopher Frueh, PhD, Jane Mahoney, PhD, RN, PMHCNS-BC
All adults admitted to The Clinic are invited to participate in this project, which evaluates clinical status during the course of their hospitalization and after discharge. Participating patients are administered structured psychiatric interviews (e.g., the SCID-I and SCID-II) at admission, as well as a battery of self-report tests that provide objective data on clinical symptoms, level of functioning, interpersonal relationships, and treatment progress and process (working relationships with treatment team members and treatment engagement). Patients are asked to complete a similar battery of self-report measures two weeks after discharge and then every three months after that for 18 months. More than 1,600 patients have participated in the study since it began in 2008.